Observational study designs for bipolar disorder - What can they tell us about treatment in acute mania?

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 4, 2009, Pages 715-721

  Reed, Catherine ^a   Novick, Diego ^a   Gonzalez Pinto, Ana ^b   Bertsch, Jordan ^c   Haro, Josep Maria ^c  

^a ELI LILLY AND COMPANY   (United States)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c PARC SANITARI SANT JOAN DE DÉU   (Spain)

Author keywords

Bipolar disorder; Combination therapy; Concomitant medication; Observational study; Treatment switching

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG SUBSTITUTION; EUROPEAN MANIA IN BIPOLAR LONGITUDINAL EVALUATION OF MEDICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; OBSERVATION; PRESCRIPTIONS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 67349184762     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.03.024     Document Type: Article

References (27)

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder, revision. Am J Psychiatry 159 4 suppl. (2002) 1-50
2. Baldessarini R.J. Treatment research in bipolar disorder. Issues and recommendations. CNS Drugs 16 (2002) 721-729
3. Baldessarini R., Henk H., Sklar A., Chang J., and Leahy L. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv 59 (2008) 1175-1183
4. Bourin M., Lambert O., and Guitton B. Treatment of acute mania - from clinical trials to recommendations for clinical practice. Hum Psychopharmacol 20 (2005) 15-26
5. Fountoulakis K.N., Vieta E., Sanchez-Moreno J., Kaprinis S.G., Goikolea J.M., and Kaprinis G.S. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 86 (2005) 1-10
6. Fountoulakis K.N., Vieta E., Siamouli M., Valenti M., Magiria S., Oral T., et al. Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder. Ann Gen Psychiatry 6 (2007) 27
7. Ghaemi S.N., Hsu D.J., Thase M.E., Wisniewski S.R., Nierenberg A.A., Miyahara S., et al. Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants. Psychiatr Serv 57 (2006) 660-665
8. Goetz I., Tohen M., Reed C., Lorenzo M., Vieta E., and the EMBLEM Advisory Board. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 9 (2007) 45-52
9. Gonzalez-Pinto A., Ballesteros J., Aldama A., Perez de Heredia J.L., Gutierrez M., Mosquera F., et al. Principal components of mania. J Affect Disord 76 (2003) 95-102
10. González-Pinto, A., Mosquera, F., Reed, C., Novick, D., Barbeito, S., Vega, P., et al. Validity and reliability of the Hamilton Depression Rating Scale (5 items) for manic and mixed bipolar disorders. J Nerv Mental Dis (in press).
11. Goodwin G.M. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17 (2003) 149-173
12. Guy W. Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology, revised (1976), National Institute of Mental Health, Rockville, Maryland
13. Haro J.M., Van Os J., Vieta E., Reed C., Lorenzo M., and Goetz I. Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study. Acta Psychiatr Scand 113 (2006) 112-120
14. Keck P.E., Marcus R., Tourkodimitris S., Ali M., Liebeskind A., Saha A., et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160 (2003) 1651-1658
15. Kupfer D.J., Frank E., Grochocinski V.J., Cluss P.A., Houck P.R., and Stapf D.A. Demographic and clinical characteristics of individuals with bipolar disorder case registry. J Clin Psychiatry 63 (2002) 120-125
16. Licht R.W., Vestergaard P., Kessing L.V., Larsen J.K., and Thomsen P.H. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl 419 (2003) 1-22
17. McElroy S.L., Altshuler L.L., Suppes T., Keck P.E., Frye M.A., Denicoff K.D., et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 158 (2001) 420-426
18. National Institute of Health and Clinical Excellence (NICE). Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Clinical Practice Guideline number 38, 2006.
19. Rosa A.R., Cruz N., Franco C., Haro J.M., Bertsch J., Reed C., et al. Why do clinicians maintain antidepressants in some patients with acute mania?. Hints from a large, observational study (EMBLEM). Abstract presented at the 16th European Congress of Psychiatry, Nice, France, April 5-9 (2008)
20. Rush A.J., Post R.M., Nolen W.A., Keck P.E., Suppes T., Altshuler L., et al. Methodological issues in developing new acute treatments for patients with bipolar illness. Biol Psychiatry 48 (2000) 615-624
21. Smith L.A., Cornelius V., Warnock A., Tacchi M.J., and Taylor D. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. Bipolar Disord 9 (2007) 551-560
22. Spearing M.K., Post R.M., Leverich G.S., Brandt D., and Nolen W. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 73 (1997) 159-171
23. Strakowski S.M., Sax K.W., McElroy S.L., Keck Jr. P.E., Hawkins J.M., and West S.A. Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first hospitalization. J Clin Psychiatry 59 (1998) 465-471
24. Vieta E., Panicali F., Goetz I., Reed C., Comes M., Tohen M., and for the EMBLEM Advisory Board. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study. J Affect Disord 106 (2008) 63-72
25. Wells K.B. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 156 (1999) 5-10
26. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S.V., MacQueen G., McIntyre R.S., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder update. Bipolar Disord 8 (2006) 721-739
27. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 (1978) 429-435